O04 In vivo assessment of prevention of lung fibrosis using the pan-PPAR agonist lanifibranor in the TbRIIDk-fib mouse model of systemic sclerosis. (12th April 2019) - Derrett-Smith, Emma; Shi-Wen, Xu; Abraham, David; Lacombe, Olivier; Broqua, Pierre; Junien, Jean-Louis; Konstantinova, Irena; Denton, Christopher P